Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed and Gemcitabine in Advanced Head and Neck Cancer
NCT00394147Phase 2Terminated
- Sponsor
- Fox Chase Cancer Center
- Start
- Oct 2006
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed, gemcitabine in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Fox Chase Cancer Center. Started Oct 2006; status: terminated.
02
Drugs
pemetrexedgemcitabine
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00394147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00394147.